Trial no.:
|
PACTR201711002738361 |
Date of Approval:
|
31/10/2017 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Comparative Efficacy of Inspiratory, Expiratory and Combined Respiratory Muscle Training on Pulmonary Functions and Chest Expansions in Acute Stroke |
Official scientific title |
Comparative Efficacy of Inspiratory, Expiratory and Combined Respiratory Muscle Training on the Pulmonary Functions and Chest Expansions in Acute Stroke Survivors |
Brief summary describing the background
and objectives of the trial
|
Stroke (cerebrovascular accident) is the sudden loss of neurological function caused by an interruption of the blood flow to the brain (O¿Sullivan et al, 2014). Ischaemic stroke is the most common type, affecting about 80% of individuals with stroke, and results when a clot blocks or impair blood flow, depriving the brain of essential oxygen and nutrients. Haemorrhagic stroke occurs when blood vessels rupture, causing leakage of blood in or around the brain. Pulmonary function is often impaired in individuals with stroke. Decreased lung volume, decreased pulmonary perfusion and vital capacity, and altered chest wall excursion are all common findings. The decreased respiratory output is accompanied by increased oxygen demands required during activity using altered and unfamiliar movement patterns (O¿Sullivan et al, 2014).
Specific objectives
i. To determine the effect of IMT on the pulmonary parameters (FEV1, FVC, FEV1/FVC, PEF) and chest expansion in acute stroke survivors.
ii. To determine the effect of EMT on the pulmonary parameters (FEV1, FVC, FEV1/FVC, PEF) and chest expansion in acute stroke survivors.
iii. To determine the effect of combined respiratory muscle training (IMT and EMT) on the pulmonary parameters (FEV1, FVC, FEV1/FVC, PEF) and chest expansion in acute stroke survivors.
iv. To determine which of the respiratory muscle training methods (IMT, EMT, and combined respiratory muscle training) will be most effective in improving the pulmonary functions and chest expansion in acute stroke survivors.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Nervous System Diseases,Stroke |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Rehabilitation |
Anticipated trial start date |
03/04/2017 |
Actual trial start date |
10/04/2017 |
Anticipated date of last follow up |
22/08/2017 |
Actual Last follow-up date |
11/09/2017 |
Anticipated target sample size (number of participants) |
62 |
Actual target sample size (number of participants) |
45 |
Recruitment status |
Completed |
Publication URL |
|
|